Search research articles
Contact Us
Filters
Showing results (191-200 of 194) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 194 results.
Hepatology (Baltimore, Md.)
|
May 9, 2015
MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4
Jun-Nian Zhou, Quan Zeng, Hai-Yang Wang, et al.
Phytopathology
|
February 8, 2024
Open Access and Reproducibility in Plant Pathology Research: Guidelines and Best Practices
Niklaus J Grünwald, Clive H Bock, Jeff H Chang, et al.
Heart (British Cardiac Society)
|
May 2, 2020
Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis
Jia-Fu Wei, Fang-Yang Huang, Tian-Yuan Xiong, et al.
Chinese Medical Journal
|
April 3, 2023
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
Chengyuan Gu, Zengjun Wang, Tianxin Lin, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 194) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 194 results.
Hepatology (Baltimore, Md.)
|
May 9, 2015
MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4
Jun-Nian Zhou, Quan Zeng, Hai-Yang Wang, et al.
Phytopathology
|
February 8, 2024
Open Access and Reproducibility in Plant Pathology Research: Guidelines and Best Practices
Niklaus J Grünwald, Clive H Bock, Jeff H Chang, et al.
Heart (British Cardiac Society)
|
May 2, 2020
Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis
Jia-Fu Wei, Fang-Yang Huang, Tian-Yuan Xiong, et al.
Chinese Medical Journal
|
April 3, 2023
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
Chengyuan Gu, Zengjun Wang, Tianxin Lin, et al.
Page
of 20